Megan Sealey

477 total citations
19 papers, 326 citations indexed

About

Megan Sealey is a scholar working on Pathology and Forensic Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Megan Sealey has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Megan Sealey's work include Alzheimer's disease research and treatments (6 papers), Multiple Sclerosis Research Studies (6 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Megan Sealey is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Multiple Sclerosis Research Studies (6 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Megan Sealey collaborates with scholars based in United Kingdom, Singapore and Switzerland. Megan Sealey's co-authors include Amritpal Mudher, Shmma Quraishe, Catherine M. Cowan, Daniel C. Anthony, Fay Probert, Tianrong Yeo, Timothy D. W. Claridge, Efthimios M. C. Skoulakis, Torsten Bossing and Sofia Grammenoudi and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Megan Sealey

17 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan Sealey United Kingdom 13 140 120 76 61 57 19 326
Riyun Yang China 10 89 0.6× 163 1.4× 34 0.4× 66 1.1× 28 0.5× 17 323
Sophie Robinson United Kingdom 7 180 1.3× 196 1.6× 26 0.3× 111 1.8× 52 0.9× 8 433
Yajuan Wu China 8 154 1.1× 144 1.2× 30 0.4× 74 1.2× 32 0.6× 15 410
Qinming Zhou China 12 52 0.4× 106 0.9× 35 0.5× 60 1.0× 42 0.7× 42 411
Sina K. Stumpf Germany 6 65 0.5× 192 1.6× 41 0.5× 54 0.9× 15 0.3× 6 383
Ofir Zmira Israel 6 72 0.5× 138 1.1× 31 0.4× 20 0.3× 22 0.4× 7 369
Carlos Lorenzana United States 4 69 0.5× 184 1.5× 140 1.8× 50 0.8× 15 0.3× 4 438
Jonathan Li Australia 8 40 0.3× 221 1.8× 50 0.7× 94 1.5× 53 0.9× 15 400
Kyoungjoo Cho South Korea 10 45 0.3× 149 1.2× 18 0.2× 90 1.5× 16 0.3× 25 340
Elisabetta Prat Italy 6 138 1.0× 97 0.8× 45 0.6× 44 0.7× 14 0.2× 7 363

Countries citing papers authored by Megan Sealey

Since Specialization
Citations

This map shows the geographic impact of Megan Sealey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Sealey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Sealey more than expected).

Fields of papers citing papers by Megan Sealey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Sealey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Sealey. The network helps show where Megan Sealey may publish in the future.

Co-authorship network of co-authors of Megan Sealey

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Sealey. A scholar is included among the top collaborators of Megan Sealey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Sealey. Megan Sealey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sealey, Megan, Mark Woodhall, Patrick Waters, et al.. (2025). Plasma N -Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD. Neurology Neuroimmunology & Neuroinflammation. 12(6). e200502–e200502.
2.
Batchelor, B.G., et al.. (2023). Tau-mediated axonal degeneration is prevented by activation of the WldS pathway. Brain Communications. 5(2). fcad052–fcad052. 4 indexed citations
3.
Chatterjee, Shreyasi, Megan Sealey, Keeley J. Brookes, et al.. (2023). Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration. PLoS ONE. 18(1). e0262792–e0262792. 13 indexed citations
4.
Larkin, James R., Tianrong Yeo, Megan Sealey, et al.. (2022). Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms. Clinical Cancer Research. 28(8). 1651–1661. 35 indexed citations
5.
Yeo, Tianrong, Marcus Augusto‐Oliveira, Megan Sealey, et al.. (2022). Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model. Journal of Neuroinflammation. 19(1). 252–252.
6.
Torres, Júlia Baguña, Megan Sealey, Marina Ziehn, et al.. (2022). Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration. Frontiers in Immunology. 13. 814064–814064. 23 indexed citations
7.
Probert, Fay, Tianrong Yeo, Yifan Zhou, et al.. (2022). Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands. Frontiers in Immunology. 12. 811351–811351. 8 indexed citations
8.
Probert, Fay, Tianrong Yeo, Yifan Zhou, et al.. (2021). Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis. Brain Communications. 3(2). fcab084–fcab084. 15 indexed citations
9.
Yeo, Tianrong, Fay Probert, Megan Sealey, et al.. (2021). Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach. Brain Communications. 3(4). fcab240–fcab240. 16 indexed citations
10.
Yeo, Tianrong, Megan Sealey, Yifan Zhou, et al.. (2020). A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application. Scientific Reports. 10(1). 12381–12381. 16 indexed citations
11.
Cowan, Catherine M., Megan Sealey, & Amritpal Mudher. (2020). Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity. Journal of Neurochemistry. 157(3). 684–694. 14 indexed citations
12.
Torres, Júlia Baguña, Megan Sealey, Rainer Kneuer, et al.. (2019). Distribution and Efficacy of Ofatumumab and Ocrelizumab in Humanized-CD20 Mice following Subcutaneous or Intravenous Administration (P2.2-052). Neurology. 92(15_supplement). 1 indexed citations
13.
Yeo, Tianrong, Fay Probert, Maciej Juryńczyk, et al.. (2019). Classifying the antibody-negative NMO syndromes. Neurology Neuroimmunology & Neuroinflammation. 6(6). e626–e626. 25 indexed citations
14.
Sealey, Megan, Catherine M. Cowan, Torsten Bossing, et al.. (2017). Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy. Neurobiology of Disease. 105. 74–83. 63 indexed citations
15.
Quraishe, Shmma, et al.. (2016). Microtubule stabilising peptides rescue tau phenotypes in-vivo. Scientific Reports. 6(1). 38224–38224. 15 indexed citations
16.
Cowan, Catherine M., Shmma Quraishe, Sarah Hands, et al.. (2015). Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers. Scientific Reports. 5(1). 17191–17191. 32 indexed citations
17.
Sinadinos, Christopher, et al.. (2013). Low Endogenous and Chemical Induced Heat Shock Protein Induction in a 0N3Rtau-Expressing Drosophila Larval Model of Alzheimer's Disease. Journal of Alzheimer s Disease. 33(4). 1117–1133. 19 indexed citations
18.
Newman, Tracey A., et al.. (2011). UsingDrosophilamodels of neurodegenerative diseases for drug discovery. Expert Opinion on Drug Discovery. 6(2). 129–140. 10 indexed citations
19.
Cowan, Catherine M., et al.. (2011). Modelling Tauopathies in Drosophila: Insights from the Fruit Fly. International Journal of Alzheimer s Disease. 2011(1). 598157–598157. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riyun Yang Breakdown of academic impact, for papers by Sophie Robinson Breakdown of academic impact, for papers by Yajuan Wu Breakdown of academic impact, for papers by Qinming Zhou Breakdown of academic impact, for papers by Sina K. Stumpf Breakdown of academic impact, for papers by Ofir Zmira Breakdown of academic impact, for papers by Carlos Lorenzana Breakdown of academic impact, for papers by Jonathan Li Breakdown of academic impact, for papers by Kyoungjoo Cho Breakdown of academic impact, for papers by Elisabetta Prat
Rankless by CCL
2026